An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
Clinical trial NCT01535664 · COMPLETED
Trial details
- NCT number
- NCT01535664
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.